# Herbert I. Hurwitz

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/herbert-i-hurwitz/

## Facts

| Field | Value |
| --- | --- |
| Citations | 35,840 |
| Field | Colorectal Cancer Treatments and Studies |
| h-index | 80 |
| i10-index | 229 |
| Last Known Institution | Duke University |
| OpenAlex ID | https://openalex.org/A5046311492 |
| ORCID iD | https://orcid.org/0000-0003-3242-9197 |
| Works | 534 |

## Researcher papers

- [Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook](https://scholariq.org/papers/bevacizumab-avastin-in-cancer-treatment-a-review-of-15-years-of-clinical/)
- [Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)](https://scholariq.org/papers/gemcitabine-plus-bevacizumab-compared-with-gemcitabine-plus-placebo-in-patients/)
- [Phase I Safety, Pharmacokinetics, and Clinical Activity Study of Lapatinib (GW572016), a Reversible Dual Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinases, in Heavily Pretreated Patients With Metastatic Carcinomas](https://scholariq.org/papers/phase-i-safety-pharmacokinetics-and-clinical-activity-study-of-lapatinib/)

## Researcher topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Researcher university

- [Duke University](https://scholariq.org/institutions/duke-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.